Cheil Bio Co

Cheil Bio Co Intangible Assets

Delisted·Feb 25, 2026

The Intangible Assets of Cheil Bio Co (052670.KQ) as of Nov 17, 2026 is 15.00 M KRW. In the previous year, Intangible Assets was 15.00 M KRW — a change of 0.00% (lower).

Intangible Assets

15.00 MKRW

YoY

0.00%

Last updated:

Intangible Assets of Cheil Bio Co is 2023 15.00 M KRW. Intangible Assets of Cheil Bio Co was 2022 15.00 M KRW. It decreases by 0.00% lower compared to the previous year.

The Cheil Bio Co Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2016
31.00 M KRW
Jan 1, 2017
31.00 M KRW
Jan 1, 2018
26.00 M KRW
Jan 1, 2019
16.00 M KRW
Jan 1, 2020
15.00 M KRW
Jan 1, 2021
15.00 M KRW
Jan 1, 2022
15.00 M KRW
Jan 1, 2023
15.00 M KRW
The Cheil Bio Co Intangible Assets history
YEARIntangible AssetsYoY
15.00 MKRW0.00%
15.00 MKRW0.00%
15.00 MKRW0.00%
15.00 MKRW-6.25%
16.00 MKRW-38.46%
26.00 MKRW-16.13%
31.00 MKRW0.00%
31.00 MKRW-61.25%
80.00 MKRW+158.06%
31.00 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co Stock analysis

What does Cheil Bio Co do? Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers. Cheil Bio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cheil Bio Co stock

Intangible Assets of Cheil Bio Co is 15.00 M KRW in 2023.

Intangible Assets of Cheil Bio Co changed from 15.00 M KRW to 15.00 M KRW, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Cheil Bio Co since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Cheil Bio Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Cheil Bio Co

All Key Metrics — Cheil Bio Co